About Us

Home  >  About Us  >  Management

Guy Chamberland , M.Sc., Ph.D., Chief Executive Officer and Chief Scientific Officer

Dr. Guy Chamberland, M.Sc., Ph.D., Master Herbalist, Chief Executive Officer and Chief Scientific Officer as of October 15, 2018 and was previously as Interim Chief Executive Officer and Chief Scientific Officer since April 2018 and June 2016, respectively. His extensive and broad-based experience in both executive and scientific roles establish Dr. Chamberland as a seasoned and knowledgeable professional in the biopharmaceutical space. Dr. Chamberland has over 22 years of experience in new drug development for the pharmaceutical industry (Canada and USA) with specific expertise in regulatory affairs, and the development and management of clinical research protocols and clinical studies for botanical medicines. He also was a member of the investment committee of the venture capital fund, Fonds Bionvation, for 7 years.

Dr. Chamberland has become a recognized expert in the field of botanical medicine, publishing, lecturing and delivering continuing education workshops to health professionals on the use of plants in the treatment of such areas as pain, anxiety, insomnia, and wound healing. He is the Professor of Botanical Medicine and Principles of clinical research at the Ecole d'Enseignement Superieur de Naturopathie du Quebec (EESNQ) and French language equivalent of the Canadian College of Naturopathic Medicine (CCNNM). He earned a diploma in Proficiency in Herbal Prescription from the Australian College of Phytotherapy, a Certified Herbalist from the Dominion College of Canada and a Master Herbalist diploma from the Dominion College of Canada. Dr. Chamberland received a B.Sc. in Agriculture from McGill University, an M.Sc. in Veterinary anatomy and physiology and a Ph.D. in Biomedical Sciences (toxicology) from the University of Montreal.

Richard Giguere , Chief Executive Officer – Tetra Natural Health Inc.

Mr. Giguere has more than 20 years’ experience in sales and marketing in the pharmaceutical industry from coast to coast. During his career, he has held various business development, management and negotiation positions and launched several new products on the Canadian market. He has worked for various pharmaceutical companies in sectors such as generics, branded products and medical devices. He has also worked with OTC, natural products and original medications. Richard is recognized for his deep ethical sense, respect of others and talent for developing long-term business relationships through flexibility and efficiency. In the past 10 years, he was also a board member at the companies for which he worked.

Sabino Di Paola , Chief Financial Officer

Mr. Di Paola, is a graduate of Concordia University, and also serves as the CFO of other publicly listed companies in Canada on the TSX-Venture exchange including, Mondias Naturals Products Inc. and UrbanGold Minerals Inc. He has close to ten years' experience in audit, finance and accounting while working as an auditor for PricewaterhouseCoopers and BDO Canada. He has been involved with numerous financing and spin out transactions and is responsible for all aspects of financial reporting and corporate governance for Tetra.

Robert Béchard , Executive Vice President, Corporate Development and Licensing

Mr. Béchard brings more than 25 years of experience in finance, venture capital, corporate banking and business development experience to his role as Executive Vice President, Corporate Development and Licensing at Tetra Bio-Pharma. Prior to joining Tetra, Mr. Béchard was a Senior Member at RBC Lifesciences, delivering top quartile returns for two separate venture capital funds with investments in American Biotech companies. During his 12-year term as a venture capitalist, Mr. Béchard, was involved in numerous investments, served on the Boards of more than 30 life science companies and oversaw the negotiation of numerous strategic alliances, partnerships, and outright sales to both pharmaceutical and biotech companies including taking several companies public both in Canada and the U.S. Mr. Béchard has also held key operating roles for an R&D management company and a drug delivery company contributing to their growth as well as serving as a consultant to the biopharmaceutical industry providing start-up assistance in areas of fundraising, strategy, and business and corporate development.

Steeve Neron , Senior Vice President, Marketing and Medical Affairs

Mr. Neron has more than 32 years’ experience in the pharmaceutical industry with demonstrated success in numerous therapeutic sectors including cardiology, rheumatology, endocrinology, women’s health, asthma/COPD, OTC and dermatology where challenging the reimbursement landscape factored prominently in his role. Prior to joining Tetra Bio-Pharma he occupied a senior marketing position at Bausch Health Canada, formerly Valeant. Steeve has held various marketing, sales, finance, material management and business development positions and has worked to launch or rejuvenate numerous market leading pharmaceutical brands including Aerius™ (antihistamine), Altace™ (hypertension), Ezetrol™ (cholesterol), Eliquis™ (anti-coagulant), Lodalis™ (cholesterol) and Contrave™ (Obesity).

Aurelia De Pauw , Ph.D, Vice President, Clinical Programs and Medical Affairs

Aurelia De Pauw holds a master’s degree and Ph.D. in Science from the Gembloux Agro-Bio Tech, University of Liege and the University of Namur, Belgium, followed by a five-year post-doctoral position in the field of stem cell therapy. After establishing her career in basic sciences and regenerative therapy, she progressed from the laboratory bench to the bedside where she gained an even deeper appreciation of the impact of research on patients and caregivers. Aurelia has extensive experience in numerous therapeutic categories including oncology, drug abuse, endocrinology, dermatology and cardiology.